TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PROVINGO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PROVINGO

ST13

US500000090282008

Classe

5, 10

Pedido

90282008

Registro

6460125

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

23

Atualização mais recente

29/04/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10

Data de depósito

27/10/2020

Data de registro

24/08/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/08/2021

Última transação

29/04/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Marseille, FR

Examinador

GRIFFIN, JAMES

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

PROVEPHARM LIFE SOLUTIONS

Representantes

Kaitlyn Garvin

Classificação técnica

Classes Nice

Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations in the nature of indigo carmine solutions for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; Chemical preparations in the nature of indigo carmine for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; Chemical preparations in the nature of indigo carmine solutions for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; indigo carmine solutions for use as a marker during gastro-intestinal endoscopy; indigo carmine solutions used as a contrast solution for medical imaging procedures; indigo carmine solutions for medical diagnostic purposes for viewing and marking tissue; indigo carmine solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas; indigo carmine solutions used for polyps or lesions resection medicines for tissue staining; indigo carmine solutions for use as a marker during visceral surgery; indigo carmine solutions for the detection of amniotic fluid leaks; indigo carmine solutions for use as a marker during cystoscopy and ureteral catheterization; indigo carmine solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; synthetic peptides for pharmaceutical use, namely, for cancer treatments, immunotherapy, cell therapy, antivirals and antibiotics; phytotherapy preparations for medical use; diagnostic preparations in vials for medical use; Drug delivery agents in the form of filled vials that facilitate the delivery of pharmaceutical preparations; pre-filled syringes for medical and clinical purposes, sold filled with indigo carmine solutions for marking tissue by injection application in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable, for the antiseptic treatment orally or topically, for marking and functional verification gynecological and urological systems, by instillation, injection or local application; all of these goods excluding food supplements, hand sanitizing preparations, insect repellents and bone growth media

Classe 10

Medical apparatus and instruments for use in exploratory endoscopy procedures in surgery, gynecology, urology, gastroenterology and medical imaging procedures; apparatus and instruments for diagnostic purposes for medical use for use in surgery, gynecology, urology and gastroenterology procedures

Publicações

Histórico de despachos e eventos da marca no USPTO.

23 publicações encontradas

R.PR

REGISTERED-PRINCIPAL REGISTER

24/08/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/06/2021

PUBO

PUBLISHED FOR OPPOSITION

08/06/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/05/2021

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

05/05/2021

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

30/04/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/04/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

27/04/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

27/04/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

27/04/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

27/04/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/04/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/04/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/04/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/04/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/04/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

15/04/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

25/03/2021

GNRT

NON-FINAL ACTION E-MAILED

25/03/2021

CNRT

NON-FINAL ACTION WRITTEN

25/03/2021

DOCK

ASSIGNED TO EXAMINER

24/03/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

17/12/2020

NWAP

NEW APPLICATION ENTERED

30/10/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PROVINGO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.